Market Overview

Cytokinetics, Incorporated (NASDAQ: CYTK)

21.79 -0.34 (-1.56%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/23/20Piper SandlerMaintainsOverweight36.0
7/23/20HC Wainwright & Co.MaintainsBuy59.0
7/16/20NeedhamMaintainsBuy45.0
7/14/20HC Wainwright & Co.MaintainsBuy38.0
7/10/20Raymond JamesInitiates Coverage OnStrong Buy39.0
7/07/20Morgan StanleyMaintainsOverweight35.0
5/12/20Morgan StanleyMaintainsOverweight29.0
5/05/20MizuhoInitiates Coverage OnBuy31.0
4/17/20Cantor FitzgeraldReiteratesOverweight23.0
4/09/20Morgan StanleyUpgradesOverweight25.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter